RNatives
Company Details
About: RNatives is a biotechnology company developing precision RNA-based gene regulating therapies by leveraging its RNAIntelTM platform which identifies small non-coding RNAs that bind directly to gene promoters to regulate gene expression. The Company is developing novel RNA-based therapies to treat ocular, CNS, and metabolic diseases, as well as cancer. The Company's technology is based on years of academic research published by Turunen et al.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
RNatives | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.